Evidence map›Paper›PMID 22069545›Full record

ArticleToxins2010

Sensing the deadliest toxin: technologies for botulinum neurotoxin detection.

Petr Capek, Tobin J Dickerson

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Toxins, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 52 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Petr CapekDepartment of Chemistry, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA. capek@scripps.edu
Tobin J Dickerson
Scripps Research Institute · US

Funding

Small Molecule Therapeutics for Botullinum Neurotoxin AU01AI082190 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI DICKERSON, TOBIN J · 2009 to 2013
$5.9M
NIAID NIH HHS AI082190NIAID NIH HHS U01 AI082190
6 · The paper itself

Abstract

Sensitive and rapid detection of botulinum neurotoxins (BoNTs), the most poisonous substances known to date, is essential for studies of medical applications of BoNTs and detection of poisoned food, as well as for response to potential bioterrorist threats. Currently, the most common method of BoNT detection is the mouse bioassay. While this assay is sensitive, it is slow, quite expensive, has limited throughput and requires sacrificing animals. Herein, we discuss and compare recently developed alternative in vitro detection methods and assess their ability to supplement or replace the mouse bioassay in the analysis of complex matrix samples.

Indexed as

Botulinum ToxinsBotulinum Toxins, Type AAnimalsBiological AssayIn Vitro TechniquesToxins, BiologicalBotulinum ToxinsBotulinum Toxins, Type AToxins, Biologicalbotulinum neurotoxinbotulismdetectionELISAendopeptidaseFRETimmuno-PCRlateral flow testmass spectrometrymouse lethality assay

Identifiers

PMID22069545
PMCPMC3206617
OpenAlexW2112732134

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.